{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T01:09:28Z","timestamp":1770512968175,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2014,6,13]],"date-time":"2014-06-13T00:00:00Z","timestamp":1402617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2014,6,13]],"date-time":"2014-06-13T00:00:00Z","timestamp":1402617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s11926-014-0432-9","type":"journal-article","created":{"date-parts":[[2014,6,12]],"date-time":"2014-06-12T07:06:55Z","timestamp":1402556815000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Vaccination in Paediatric Rheumatology"],"prefix":"10.1007","volume":"16","author":[{"given":"Jonathan D.","family":"Akikusa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nigel W.","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,6,13]]},"reference":[{"issue":"8","key":"432_CR1","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1093\/rheumatology\/41.8.937","volume":"41","author":"K Davies","year":"2002","unstructured":"Davies K, Woo P. British Paediatric Rheumatology G Immunization in rheumatic diseases of childhood: an audit of the clinical practice of British Paediatric Rheumatology Group members and a review of the evidence. Rheumatology (Oxford). 2002;41(8):937\u201341.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"432_CR2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00296-013-2907-9","volume":"34","author":"D Papadopoulou","year":"2014","unstructured":"Papadopoulou D. Sipsas NV Comparison of national clinical practice guidelines and recommendations on vaccination of adult patients with autoimmune rheumatic diseases. Rheumatol Int. 2014;34(2):151\u201363.","journal-title":"Rheumatol Int"},{"issue":"11","key":"432_CR3","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1093\/rheumatology\/kes175","volume":"51","author":"MP Morin","year":"2012","unstructured":"Morin MP, Quach C, Fortin E, et al. Vaccination coverage in children with juvenile idiopathic arthritis followed at a paediatric tertiary care centre. Rheumatology (Oxford). 2012;51(11):2046\u201350.","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"432_CR4","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/RHU.0b013e3182611547","volume":"18","author":"EM McCarthy","year":"2012","unstructured":"McCarthy EM, Azeez MA, Fitzpatrick FM, et al. Knowledge, attitudes, and clinical practice of rheumatologists in vaccination of the at-risk rheumatology patient population. J Clin Rheumatol. 2012;18(5):237\u201341.","journal-title":"J Clin Rheumatol"},{"issue":"10","key":"432_CR5","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1136\/ard.2011.150193","volume":"70","author":"MW Heijstek","year":"2011","unstructured":"Heijstek MW, de Bruin LM O, Bijl M, et al. EULAR recommendations for vaccination in paediatric patients with rheumatic diseases. Ann Rheum Dis. 2011;70(10):1704\u201312. Presents the recommendations of the EULAR working group on vaccinations in PRDs\u2014the most comprehensive effort to provide evidence-based recommendations in this field to date.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"432_CR6","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1136\/ard.2010.137216","volume":"70","author":"S van Assen","year":"2011","unstructured":"van Assen S, Agmon-Levin N, Elkayam O, et al. EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis. 2011;70(3):414\u201322. Presents the recommendations of the EULAR working group on vaccinations in adult rheumatic diseases and provides useful context for the paediatric recommendations.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"432_CR7","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.autrev.2011.08.010","volume":"11","author":"MW Heijstek","year":"2011","unstructured":"Heijstek MW, de Bruin LM O, Borrow R, et al. Vaccination in paediatric patients with auto-immune rheumatic diseases: a systemic literature review for the European League against Rheumatism evidence-based recommendations. Autoimmun Rev. 2011;11(2):112\u201322. Provides details of the search method and of the papers used to derive the subsequent EULAR recommendations for vaccination in PRDs.","journal-title":"Autoimmun Rev"},{"issue":"6","key":"432_CR8","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.autrev.2010.12.003","volume":"10","author":"S van Assen","year":"2011","unstructured":"van Assen S, Elkayam O, Agmon-Levin N, et al. Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases. Autoimmun Rev. 2011;10(6):341\u201352.","journal-title":"Autoimmun Rev"},{"key":"432_CR9","unstructured":"WHO. Summary of WHO position papers - Recommendations for Routine Immunisation. 2014 [cited 2014 28 April]; Available from: http:\/\/www.who.int\/immunization\/policy\/Immunization_routine_table1.pdf?ua=1."},{"issue":"37","key":"432_CR10","doi-asserted-by":"publisher","first-page":"5041","DOI":"10.1016\/j.vaccine.2009.06.052","volume":"27","author":"S Korematsu","year":"2009","unstructured":"Korematsu S, Miyahara H, Kawano T, et al. A relapse of systemic type juvenile idiopathic arthritis after a rubella vaccination in a patient during a long-term remission period. Vaccine. 2009;27(37):5041\u20132.","journal-title":"Vaccine"},{"issue":"4","key":"432_CR11","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1136\/ard.34.4.354","volume":"34","author":"CC Linnemann Jr","year":"1975","unstructured":"Linnemann Jr CC, Levinson JE, Buncher CR, et al. Rubella antibody levels in juvenile rheumatoid arthritis. Ann Rheum Dis. 1975;34(4):354\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"432_CR12","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1093\/infdis\/jir660","volume":"204","author":"T Banovic","year":"2011","unstructured":"Banovic T, Yanilla M, Simmons R, et al. Disseminated varicella infection caused by varicella vaccine strain in a child with low invariant natural killer T cells and diminished CD1d expression. J Infect Dis. 2011;204(12):1893\u2013901.","journal-title":"J Infect Dis"},{"issue":"2","key":"432_CR13","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0022-3476(94)70318-3","volume":"124","author":"WJ Monafo","year":"1994","unstructured":"Monafo WJ, Haslam DB, Roberts RL, et al. Disseminated measles infection after vaccination in a child with a congenital immunodeficiency. J Pediatr. 1994;124(2):273\u20136.","journal-title":"J Pediatr"},{"issue":"6","key":"432_CR14","doi-asserted-by":"publisher","first-page":"e420","DOI":"10.1016\/j.ijid.2009.02.008","volume":"13","author":"M Sadeghi-Shabestari","year":"2009","unstructured":"Sadeghi-Shabestari M. Rezaei N Disseminated bacille Calmette-Guerin in Iranian children with severe combined immunodeficiency. Int J Infect Dis. 2009;13(6):e420\u20133.","journal-title":"Int J Infect Dis"},{"issue":"10","key":"432_CR15","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1136\/ard.2006.063586","volume":"66","author":"MW Heijstek","year":"2007","unstructured":"Heijstek MW, Pileggi GC, Zonneveld-Huijssoon E, et al. Safety of measles, mumps and rubella vaccination in juvenile idiopathic arthritis. Ann Rheum Dis. 2007;66(10):1384\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"432_CR16","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/rheumatology\/ken436","volume":"48","author":"S Borte","year":"2009","unstructured":"Borte S, Liebert UG, Borte M, et al. Efficacy of measles, mumps and rubella revaccination in children with juvenile idiopathic arthritis treated with methotrexate and etanercept. Rheumatology (Oxford). 2009;48(2):144\u20138.","journal-title":"Rheumatology (Oxford)"},{"issue":"23","key":"432_CR17","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1001\/jama.2013.6768","volume":"309","author":"MW Heijstek","year":"2013","unstructured":"Heijstek MW, Kamphuis S, Armbrust W, et al. Effects of the live attenuated measles-mumps-rubella booster vaccination on disease activity in patients with juvenile idiopathic arthritis: a randomized trial. JAMA. 2013;309(23):2449\u201356. Prospective randomised trials are rare in this field. This study confirmed the safety and immunogenicity of MMR booster vaccine for JIA patients, including those on low-dose methotrexate.","journal-title":"JAMA"},{"issue":"6","key":"432_CR18","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1136\/annrheumdis-2011-200637","volume":"71","author":"MW Heijstek","year":"2012","unstructured":"Heijstek MW, van Gageldonk PG, Berbers GA, et al. Differences in persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between children with rheumatic disease and healthy controls: a retrospective cross-sectional study. Ann Rheum Dis. 2012;71(6):948\u201354. This study suggests that seroprotection may wane in children with PRDs, leaving a significant proportion potentially vulnerable to VPDs as they get older. Particularly concerning was the loss of immunity to rubella.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"432_CR19","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/nrrheum.2013.95","volume":"9","author":"CA Silva","year":"2013","unstructured":"Silva CA, Aikawa NE. Bonfa E Vaccinations in juvenile chronic inflammatory diseases: an update. Nat Rev Rheumatol. 2013;9(9):532\u201343.","journal-title":"Nat Rev Rheumatol"},{"key":"432_CR20","unstructured":"WHO. WHO recommendations for the post-pandemic period - Pandemic (H1N1) 2009 briefing note 23. 2014; Available from: http:\/\/www.who.int\/csr\/disease\/swineflu\/notes\/briefing_20100810\/en\/."},{"issue":"1","key":"432_CR21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3899\/jrheum.110721","volume":"39","author":"NE Aikawa","year":"2012","unstructured":"Aikawa NE, Campos LM, Silva CA, et al. Glucocorticoid: major factor for reduced immunogenicity of 2009 influenza A (H1N1) vaccine in patients with juvenile autoimmune rheumatic disease. J Rheumatol. 2012;39(1):167\u201373.","journal-title":"J Rheumatol"},{"issue":"1","key":"432_CR22","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3109\/03009742.2012.709272","volume":"42","author":"NE Aikawa","year":"2013","unstructured":"Aikawa NE, Campos LM, Goldenstein-Schainberg C, et al. Effective seroconversion and safety following the pandemic influenza vaccination (anti-H1N1) in patients with juvenile idiopathic arthritis. Scand J Rheumatol. 2013;42(1):34\u201340.","journal-title":"Scand J Rheumatol"},{"issue":"7","key":"432_CR23","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1002\/acr.21948","volume":"65","author":"LM Campos","year":"2013","unstructured":"Campos LM, Silva CA, Aikawa NE, et al. High disease activity: an independent factor for reduced immunogenicity of the pandemic influenza a vaccine in patients with juvenile systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2013;65(7):1121\u20137.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"432_CR24","unstructured":"Guissa VR, Pereira RM, Sallum AM, et al. Influenza A H1N1\/2009 vaccine in juvenile dermatomyositis: reduced immunogenicity in patients under immunosuppressive therapy. Clin Exp Rheumatol. 2012;30(4):583\u20138. This reference and references 21, 22 and 23 detail the extensive work done by this group in determining the safety and immunogenicity of influenza H1N1\/2009 vaccine for children with PRDs."},{"key":"432_CR25","unstructured":"PRevention CfDCa. Seasonal Influenza (Flu). 2014 [cited 2014 30th April]; Available from: http:\/\/www.cdc.gov\/flu\/protect\/children.htm."},{"issue":"13","key":"432_CR26","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1177\/0961203313505926","volume":"22","author":"NE Aikawa","year":"2013","unstructured":"Aikawa NE, Trudes G, Campos LM, et al. Immunogenicity and safety of two doses of a non-adjuvanted influenza A H1N1\/2009 vaccine in young autoimmune rheumatic diseases patients. Lupus. 2013;22(13):1394\u20138.","journal-title":"Lupus"},{"issue":"Suppl 10","key":"432_CR27","first-page":"226","volume":"60","author":"NG Singer","year":"2009","unstructured":"Singer NG, Wallette M, Tomanova-Soltys I, et al. Interim safety data of Gardasil in a Trial in Females with JIA and Seronegative Arthritis [Abstract]. Arthritis Rheum. 2009;60 Suppl 10:226.","journal-title":"Arthritis Rheum"},{"key":"432_CR28","doi-asserted-by":"publisher","unstructured":"Heijstek MW, Scherpenisse M, Groot N, et al. Immunogenicity and safety of the bivalent HPV vaccine in female patients with juvenile idiopathic arthritis: a prospective controlled observational cohort study. Ann Rheum Dis. 2013. doi:10.1136\/annrheumdis-2013-203429.","DOI":"10.1136\/annrheumdis-2013-203429"},{"key":"432_CR29","doi-asserted-by":"crossref","unstructured":"Heijstek MW, Scherpenisse M, Groot N, et al. Immunogenicity of the bivalent human papillomavirus vaccine in adolescents with juvenile systemic lupus erythematosus or juvenile dermatomyositis. J Rheumatol. 2013;40(9):1626\u20137. This reference and reference 28 provide the only data currently available regarding immunogenicity of HPV vaccine of any type in PRDs.","DOI":"10.3899\/jrheum.130246"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-014-0432-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11926-014-0432-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-014-0432-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-014-0432-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T22:02:09Z","timestamp":1744149729000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11926-014-0432-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,13]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["432"],"URL":"https:\/\/doi.org\/10.1007\/s11926-014-0432-9","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,13]]},"assertion":[{"value":"13 June 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"432"}}